nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolvaptan—Zafirlukast—Glyburide—type 2 diabetes mellitus	0.408	1	CrCrCtD
Tolvaptan—CYP3A4—type 2 diabetes mellitus	0.155	1	CbGaD
Tolvaptan—ABCB1—Linagliptin—type 2 diabetes mellitus	0.0352	0.133	CbGbCtD
Tolvaptan—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.0314	0.118	CbGbCtD
Tolvaptan—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.0227	0.0854	CbGbCtD
Tolvaptan—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0211	0.0794	CbGbCtD
Tolvaptan—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0188	0.0708	CbGbCtD
Tolvaptan—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0172	0.0648	CbGbCtD
Tolvaptan—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.0156	0.0587	CbGbCtD
Tolvaptan—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.015	0.0566	CbGbCtD
Tolvaptan—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0136	0.0512	CbGbCtD
Tolvaptan—ABCB1—Glyburide—type 2 diabetes mellitus	0.0116	0.0437	CbGbCtD
Tolvaptan—ABCB1—Losartan—type 2 diabetes mellitus	0.0106	0.04	CbGbCtD
Tolvaptan—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.0103	0.0388	CbGbCtD
Tolvaptan—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00987	0.0372	CbGbCtD
Tolvaptan—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00987	0.0372	CbGbCtD
Tolvaptan—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00933	0.0352	CbGbCtD
Tolvaptan—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00695	0.0262	CbGbCtD
Tolvaptan—CYP3A4—Losartan—type 2 diabetes mellitus	0.00636	0.024	CbGbCtD
Tolvaptan—Zafirlukast—CYP2E1—type 2 diabetes mellitus	0.00047	0.221	CrCbGaD
Tolvaptan—Zafirlukast—CYP1A2—type 2 diabetes mellitus	0.000447	0.21	CrCbGaD
Tolvaptan—Conivaptan—CYP3A4—type 2 diabetes mellitus	0.000444	0.209	CrCbGaD
Tolvaptan—Zafirlukast—CYP3A4—type 2 diabetes mellitus	0.000296	0.139	CrCbGaD
Tolvaptan—Vismodegib—CYP3A4—type 2 diabetes mellitus	0.000251	0.118	CrCbGaD
Tolvaptan—Vismodegib—ALB—type 2 diabetes mellitus	0.000219	0.103	CrCbGaD
Tolvaptan—Nervous system disorder—Bromocriptine—type 2 diabetes mellitus	0.000178	0.00168	CcSEcCtD
Tolvaptan—Feeling abnormal—Glipizide—type 2 diabetes mellitus	0.000177	0.00167	CcSEcCtD
Tolvaptan—Asthenia—Rosiglitazone—type 2 diabetes mellitus	0.000176	0.00167	CcSEcCtD
Tolvaptan—Orthostatic hypotension—Ramipril—type 2 diabetes mellitus	0.000176	0.00166	CcSEcCtD
Tolvaptan—Skin disorder—Bromocriptine—type 2 diabetes mellitus	0.000176	0.00166	CcSEcCtD
Tolvaptan—Hyperglycaemia—Losartan—type 2 diabetes mellitus	0.000175	0.00165	CcSEcCtD
Tolvaptan—Decreased appetite—Glimepiride—type 2 diabetes mellitus	0.000174	0.00165	CcSEcCtD
Tolvaptan—Angiopathy—Valsartan—type 2 diabetes mellitus	0.000174	0.00165	CcSEcCtD
Tolvaptan—Breast disorder—Ramipril—type 2 diabetes mellitus	0.000174	0.00164	CcSEcCtD
Tolvaptan—Decreased appetite—Sitagliptin—type 2 diabetes mellitus	0.000174	0.00164	CcSEcCtD
Tolvaptan—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.000174	0.00164	CcSEcCtD
Tolvaptan—Immune system disorder—Valsartan—type 2 diabetes mellitus	0.000174	0.00164	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Glimepiride—type 2 diabetes mellitus	0.000173	0.00164	CcSEcCtD
Tolvaptan—Mediastinal disorder—Valsartan—type 2 diabetes mellitus	0.000173	0.00164	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Sitagliptin—type 2 diabetes mellitus	0.000173	0.00163	CcSEcCtD
Tolvaptan—Anorexia—Bromocriptine—type 2 diabetes mellitus	0.000173	0.00163	CcSEcCtD
Tolvaptan—Connective tissue disorder—Metformin—type 2 diabetes mellitus	0.000172	0.00162	CcSEcCtD
Tolvaptan—Immune system disorder—Orlistat—type 2 diabetes mellitus	0.000172	0.00162	CcSEcCtD
Tolvaptan—Mediastinal disorder—Orlistat—type 2 diabetes mellitus	0.000171	0.00162	CcSEcCtD
Tolvaptan—Constipation—Sitagliptin—type 2 diabetes mellitus	0.000171	0.00162	CcSEcCtD
Tolvaptan—Renal failure—Losartan—type 2 diabetes mellitus	0.00017	0.00161	CcSEcCtD
Tolvaptan—Feeling abnormal—Pioglitazone—type 2 diabetes mellitus	0.00017	0.0016	CcSEcCtD
Tolvaptan—Ill-defined disorder—Gliclazide—type 2 diabetes mellitus	0.000169	0.0016	CcSEcCtD
Tolvaptan—Diarrhoea—Rosiglitazone—type 2 diabetes mellitus	0.000168	0.00159	CcSEcCtD
Tolvaptan—Malnutrition—Valsartan—type 2 diabetes mellitus	0.000167	0.00158	CcSEcCtD
Tolvaptan—Feeling abnormal—Glimepiride—type 2 diabetes mellitus	0.000165	0.00156	CcSEcCtD
Tolvaptan—Malnutrition—Orlistat—type 2 diabetes mellitus	0.000165	0.00156	CcSEcCtD
Tolvaptan—Feeling abnormal—Sitagliptin—type 2 diabetes mellitus	0.000165	0.00156	CcSEcCtD
Tolvaptan—Malaise—Gliclazide—type 2 diabetes mellitus	0.000164	0.00155	CcSEcCtD
Tolvaptan—Dysgeusia—Valsartan—type 2 diabetes mellitus	0.000164	0.00155	CcSEcCtD
Tolvaptan—Urinary tract disorder—Irbesartan—type 2 diabetes mellitus	0.000163	0.00154	CcSEcCtD
Tolvaptan—Headache—Repaglinide—type 2 diabetes mellitus	0.000163	0.00154	CcSEcCtD
Tolvaptan—Shock—Glyburide—type 2 diabetes mellitus	0.000163	0.00154	CcSEcCtD
Tolvaptan—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000162	0.00153	CcSEcCtD
Tolvaptan—Cardiac disorder—Metformin—type 2 diabetes mellitus	0.000162	0.00153	CcSEcCtD
Tolvaptan—Nervous system disorder—Glyburide—type 2 diabetes mellitus	0.000162	0.00153	CcSEcCtD
Tolvaptan—Connective tissue disorder—Irbesartan—type 2 diabetes mellitus	0.000162	0.00153	CcSEcCtD
Tolvaptan—Urethral disorder—Irbesartan—type 2 diabetes mellitus	0.000162	0.00153	CcSEcCtD
Tolvaptan—Dysgeusia—Orlistat—type 2 diabetes mellitus	0.000162	0.00153	CcSEcCtD
Tolvaptan—Loss of consciousness—Gliclazide—type 2 diabetes mellitus	0.00016	0.00151	CcSEcCtD
Tolvaptan—Angiopathy—Metformin—type 2 diabetes mellitus	0.000159	0.0015	CcSEcCtD
Tolvaptan—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.000158	0.0015	CcSEcCtD
Tolvaptan—Immune system disorder—Metformin—type 2 diabetes mellitus	0.000158	0.00149	CcSEcCtD
Tolvaptan—Anorexia—Glyburide—type 2 diabetes mellitus	0.000158	0.00149	CcSEcCtD
Tolvaptan—Mediastinal disorder—Metformin—type 2 diabetes mellitus	0.000158	0.00149	CcSEcCtD
Tolvaptan—Decreased appetite—Bromocriptine—type 2 diabetes mellitus	0.000157	0.00149	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Bromocriptine—type 2 diabetes mellitus	0.000156	0.00148	CcSEcCtD
Tolvaptan—Constipation—Bromocriptine—type 2 diabetes mellitus	0.000155	0.00146	CcSEcCtD
Tolvaptan—Nausea—Repaglinide—type 2 diabetes mellitus	0.000154	0.00146	CcSEcCtD
Tolvaptan—Asthenia—Glipizide—type 2 diabetes mellitus	0.000154	0.00146	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Gliclazide—type 2 diabetes mellitus	0.000154	0.00145	CcSEcCtD
Tolvaptan—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000154	0.00145	CcSEcCtD
Tolvaptan—Ill-defined disorder—Orlistat—type 2 diabetes mellitus	0.000153	0.00145	CcSEcCtD
Tolvaptan—Cardiac disorder—Irbesartan—type 2 diabetes mellitus	0.000153	0.00145	CcSEcCtD
Tolvaptan—Discomfort—Gliclazide—type 2 diabetes mellitus	0.000153	0.00145	CcSEcCtD
Tolvaptan—Malnutrition—Metformin—type 2 diabetes mellitus	0.000152	0.00144	CcSEcCtD
Tolvaptan—Pruritus—Glipizide—type 2 diabetes mellitus	0.000152	0.00144	CcSEcCtD
Tolvaptan—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.000152	0.00143	CcSEcCtD
Tolvaptan—Dry mouth—Gliclazide—type 2 diabetes mellitus	0.000152	0.00143	CcSEcCtD
Tolvaptan—Syncope—Valsartan—type 2 diabetes mellitus	0.00015	0.00142	CcSEcCtD
Tolvaptan—Angiopathy—Irbesartan—type 2 diabetes mellitus	0.00015	0.00142	CcSEcCtD
Tolvaptan—Dysgeusia—Metformin—type 2 diabetes mellitus	0.000149	0.00141	CcSEcCtD
Tolvaptan—Feeling abnormal—Bromocriptine—type 2 diabetes mellitus	0.000149	0.00141	CcSEcCtD
Tolvaptan—Immune system disorder—Irbesartan—type 2 diabetes mellitus	0.000149	0.00141	CcSEcCtD
Tolvaptan—Malaise—Orlistat—type 2 diabetes mellitus	0.000149	0.00141	CcSEcCtD
Tolvaptan—Mediastinal disorder—Irbesartan—type 2 diabetes mellitus	0.000149	0.00141	CcSEcCtD
Tolvaptan—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000148	0.0014	CcSEcCtD
Tolvaptan—Asthenia—Pioglitazone—type 2 diabetes mellitus	0.000148	0.0014	CcSEcCtD
Tolvaptan—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000147	0.00139	CcSEcCtD
Tolvaptan—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000147	0.00139	CcSEcCtD
Tolvaptan—Loss of consciousness—Valsartan—type 2 diabetes mellitus	0.000147	0.00139	CcSEcCtD
Tolvaptan—Renal failure—Ramipril—type 2 diabetes mellitus	0.000146	0.00138	CcSEcCtD
Tolvaptan—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000146	0.00138	CcSEcCtD
Tolvaptan—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	0.000146	0.00138	CcSEcCtD
Tolvaptan—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.000144	0.00136	CcSEcCtD
Tolvaptan—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000144	0.00136	CcSEcCtD
Tolvaptan—Decreased appetite—Glyburide—type 2 diabetes mellitus	0.000144	0.00136	CcSEcCtD
Tolvaptan—Malnutrition—Irbesartan—type 2 diabetes mellitus	0.000144	0.00136	CcSEcCtD
Tolvaptan—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000144	0.00136	CcSEcCtD
Tolvaptan—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.000143	0.00135	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000143	0.00135	CcSEcCtD
Tolvaptan—Dizziness—Glipizide—type 2 diabetes mellitus	0.000142	0.00134	CcSEcCtD
Tolvaptan—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000142	0.00134	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.000141	0.00134	CcSEcCtD
Tolvaptan—Ill-defined disorder—Metformin—type 2 diabetes mellitus	0.000141	0.00134	CcSEcCtD
Tolvaptan—Angiopathy—Losartan—type 2 diabetes mellitus	0.000141	0.00133	CcSEcCtD
Tolvaptan—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000141	0.00133	CcSEcCtD
Tolvaptan—Dysgeusia—Irbesartan—type 2 diabetes mellitus	0.000141	0.00133	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.00014	0.00132	CcSEcCtD
Tolvaptan—Dry mouth—Valsartan—type 2 diabetes mellitus	0.000139	0.00132	CcSEcCtD
Tolvaptan—Discomfort—Orlistat—type 2 diabetes mellitus	0.000139	0.00131	CcSEcCtD
Tolvaptan—Dry mouth—Orlistat—type 2 diabetes mellitus	0.000138	0.0013	CcSEcCtD
Tolvaptan—Malaise—Metformin—type 2 diabetes mellitus	0.000137	0.0013	CcSEcCtD
Tolvaptan—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000137	0.0013	CcSEcCtD
Tolvaptan—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000137	0.00129	CcSEcCtD
Tolvaptan—Syncope—Metformin—type 2 diabetes mellitus	0.000137	0.00129	CcSEcCtD
Tolvaptan—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.000137	0.00129	CcSEcCtD
Tolvaptan—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.000136	0.00129	CcSEcCtD
Tolvaptan—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000136	0.00129	CcSEcCtD
Tolvaptan—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000135	0.00127	CcSEcCtD
Tolvaptan—Headache—Glipizide—type 2 diabetes mellitus	0.000135	0.00127	CcSEcCtD
Tolvaptan—Shock—Valsartan—type 2 diabetes mellitus	0.000134	0.00127	CcSEcCtD
Tolvaptan—Loss of consciousness—Metformin—type 2 diabetes mellitus	0.000134	0.00126	CcSEcCtD
Tolvaptan—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000134	0.00126	CcSEcCtD
Tolvaptan—Ill-defined disorder—Irbesartan—type 2 diabetes mellitus	0.000133	0.00126	CcSEcCtD
Tolvaptan—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000133	0.00125	CcSEcCtD
Tolvaptan—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000133	0.00125	CcSEcCtD
Tolvaptan—Dysgeusia—Losartan—type 2 diabetes mellitus	0.000133	0.00125	CcSEcCtD
Tolvaptan—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000132	0.00125	CcSEcCtD
Tolvaptan—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000132	0.00125	CcSEcCtD
Tolvaptan—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000131	0.00124	CcSEcCtD
Tolvaptan—Connective tissue disorder—Ramipril—type 2 diabetes mellitus	0.000131	0.00124	CcSEcCtD
Tolvaptan—Anorexia—Valsartan—type 2 diabetes mellitus	0.00013	0.00123	CcSEcCtD
Tolvaptan—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.00013	0.00123	CcSEcCtD
Tolvaptan—Malaise—Irbesartan—type 2 diabetes mellitus	0.00013	0.00122	CcSEcCtD
Tolvaptan—Headache—Pioglitazone—type 2 diabetes mellitus	0.000129	0.00122	CcSEcCtD
Tolvaptan—Syncope—Irbesartan—type 2 diabetes mellitus	0.000129	0.00122	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000129	0.00122	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000128	0.00121	CcSEcCtD
Tolvaptan—Discomfort—Metformin—type 2 diabetes mellitus	0.000128	0.00121	CcSEcCtD
Tolvaptan—Nausea—Glipizide—type 2 diabetes mellitus	0.000128	0.00121	CcSEcCtD
Tolvaptan—Constipation—Gliclazide—type 2 diabetes mellitus	0.000127	0.0012	CcSEcCtD
Tolvaptan—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	0.000126	0.00119	CcSEcCtD
Tolvaptan—Headache—Glimepiride—type 2 diabetes mellitus	0.000126	0.00119	CcSEcCtD
Tolvaptan—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.000126	0.00119	CcSEcCtD
Tolvaptan—Headache—Sitagliptin—type 2 diabetes mellitus	0.000125	0.00118	CcSEcCtD
Tolvaptan—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000124	0.00117	CcSEcCtD
Tolvaptan—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000122	0.00116	CcSEcCtD
Tolvaptan—Shock—Metformin—type 2 diabetes mellitus	0.000122	0.00116	CcSEcCtD
Tolvaptan—Malaise—Losartan—type 2 diabetes mellitus	0.000122	0.00115	CcSEcCtD
Tolvaptan—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000122	0.00115	CcSEcCtD
Tolvaptan—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000122	0.00115	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000122	0.00115	CcSEcCtD
Tolvaptan—Syncope—Losartan—type 2 diabetes mellitus	0.000121	0.00115	CcSEcCtD
Tolvaptan—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000121	0.00114	CcSEcCtD
Tolvaptan—Skin disorder—Metformin—type 2 diabetes mellitus	0.000121	0.00114	CcSEcCtD
Tolvaptan—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.00012	0.00114	CcSEcCtD
Tolvaptan—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.00012	0.00113	CcSEcCtD
Tolvaptan—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.00012	0.00113	CcSEcCtD
Tolvaptan—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.00012	0.00113	CcSEcCtD
Tolvaptan—Nausea—Glimepiride—type 2 diabetes mellitus	0.000119	0.00113	CcSEcCtD
Tolvaptan—Loss of consciousness—Losartan—type 2 diabetes mellitus	0.000119	0.00112	CcSEcCtD
Tolvaptan—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000119	0.00112	CcSEcCtD
Tolvaptan—Asthenia—Glyburide—type 2 diabetes mellitus	0.000119	0.00112	CcSEcCtD
Tolvaptan—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000119	0.00112	CcSEcCtD
Tolvaptan—Anorexia—Metformin—type 2 diabetes mellitus	0.000119	0.00112	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000118	0.00111	CcSEcCtD
Tolvaptan—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000117	0.00111	CcSEcCtD
Tolvaptan—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000117	0.00111	CcSEcCtD
Tolvaptan—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000117	0.00111	CcSEcCtD
Tolvaptan—Pruritus—Glyburide—type 2 diabetes mellitus	0.000117	0.00111	CcSEcCtD
Tolvaptan—Constipation—Valsartan—type 2 diabetes mellitus	0.000117	0.0011	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000116	0.0011	CcSEcCtD
Tolvaptan—Malnutrition—Ramipril—type 2 diabetes mellitus	0.000116	0.0011	CcSEcCtD
Tolvaptan—Shock—Irbesartan—type 2 diabetes mellitus	0.000115	0.00109	CcSEcCtD
Tolvaptan—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000115	0.00109	CcSEcCtD
Tolvaptan—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000114	0.00108	CcSEcCtD
Tolvaptan—Discomfort—Losartan—type 2 diabetes mellitus	0.000114	0.00108	CcSEcCtD
Tolvaptan—Dysgeusia—Ramipril—type 2 diabetes mellitus	0.000114	0.00107	CcSEcCtD
Tolvaptan—Headache—Bromocriptine—type 2 diabetes mellitus	0.000113	0.00107	CcSEcCtD
Tolvaptan—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000113	0.00107	CcSEcCtD
Tolvaptan—Dry mouth—Losartan—type 2 diabetes mellitus	0.000113	0.00106	CcSEcCtD
Tolvaptan—Anorexia—Irbesartan—type 2 diabetes mellitus	0.000112	0.00106	CcSEcCtD
Tolvaptan—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000111	0.00105	CcSEcCtD
Tolvaptan—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.00011	0.00104	CcSEcCtD
Tolvaptan—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.00011	0.00103	CcSEcCtD
Tolvaptan—Shock—Losartan—type 2 diabetes mellitus	0.000109	0.00103	CcSEcCtD
Tolvaptan—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.000108	0.00102	CcSEcCtD
Tolvaptan—Decreased appetite—Metformin—type 2 diabetes mellitus	0.000108	0.00102	CcSEcCtD
Tolvaptan—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	0.000108	0.00102	CcSEcCtD
Tolvaptan—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000108	0.00102	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000107	0.00101	CcSEcCtD
Tolvaptan—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000107	0.00101	CcSEcCtD
Tolvaptan—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000107	0.00101	CcSEcCtD
Tolvaptan—Constipation—Metformin—type 2 diabetes mellitus	0.000106	0.001	CcSEcCtD
Tolvaptan—Anorexia—Losartan—type 2 diabetes mellitus	0.000105	0.000994	CcSEcCtD
Tolvaptan—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000105	0.000993	CcSEcCtD
Tolvaptan—Malaise—Ramipril—type 2 diabetes mellitus	0.000105	0.000988	CcSEcCtD
Tolvaptan—Syncope—Ramipril—type 2 diabetes mellitus	0.000104	0.000983	CcSEcCtD
Tolvaptan—Headache—Glyburide—type 2 diabetes mellitus	0.000104	0.000979	CcSEcCtD
Tolvaptan—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000102	0.000968	CcSEcCtD
Tolvaptan—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000102	0.000964	CcSEcCtD
Tolvaptan—Loss of consciousness—Ramipril—type 2 diabetes mellitus	0.000102	0.000963	CcSEcCtD
Tolvaptan—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000102	0.000961	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000101	0.000957	CcSEcCtD
Tolvaptan—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000101	0.00095	CcSEcCtD
Tolvaptan—Constipation—Irbesartan—type 2 diabetes mellitus	0.0001	0.000948	CcSEcCtD
Tolvaptan—Hypersensitivity—Orlistat—type 2 diabetes mellitus	9.94e-05	0.000939	CcSEcCtD
Tolvaptan—Nausea—Glyburide—type 2 diabetes mellitus	9.83e-05	0.000929	CcSEcCtD
Tolvaptan—Dizziness—Gliclazide—type 2 diabetes mellitus	9.83e-05	0.000928	CcSEcCtD
Tolvaptan—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	9.81e-05	0.000927	CcSEcCtD
Tolvaptan—Asthenia—Valsartan—type 2 diabetes mellitus	9.8e-05	0.000925	CcSEcCtD
Tolvaptan—Discomfort—Ramipril—type 2 diabetes mellitus	9.76e-05	0.000922	CcSEcCtD
Tolvaptan—Asthenia—Orlistat—type 2 diabetes mellitus	9.68e-05	0.000914	CcSEcCtD
Tolvaptan—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	9.67e-05	0.000913	CcSEcCtD
Tolvaptan—Pruritus—Valsartan—type 2 diabetes mellitus	9.66e-05	0.000913	CcSEcCtD
Tolvaptan—Dry mouth—Ramipril—type 2 diabetes mellitus	9.66e-05	0.000913	CcSEcCtD
Tolvaptan—Decreased appetite—Losartan—type 2 diabetes mellitus	9.6e-05	0.000907	CcSEcCtD
Tolvaptan—Pruritus—Orlistat—type 2 diabetes mellitus	9.55e-05	0.000902	CcSEcCtD
Tolvaptan—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	9.47e-05	0.000894	CcSEcCtD
Tolvaptan—Constipation—Losartan—type 2 diabetes mellitus	9.44e-05	0.000892	CcSEcCtD
Tolvaptan—Diarrhoea—Valsartan—type 2 diabetes mellitus	9.34e-05	0.000883	CcSEcCtD
Tolvaptan—Shock—Ramipril—type 2 diabetes mellitus	9.32e-05	0.00088	CcSEcCtD
Tolvaptan—Headache—Gliclazide—type 2 diabetes mellitus	9.31e-05	0.000879	CcSEcCtD
Tolvaptan—Nervous system disorder—Ramipril—type 2 diabetes mellitus	9.29e-05	0.000877	CcSEcCtD
Tolvaptan—Body temperature increased—Irbesartan—type 2 diabetes mellitus	9.28e-05	0.000876	CcSEcCtD
Tolvaptan—Diarrhoea—Orlistat—type 2 diabetes mellitus	9.23e-05	0.000872	CcSEcCtD
Tolvaptan—Skin disorder—Ramipril—type 2 diabetes mellitus	9.2e-05	0.000869	CcSEcCtD
Tolvaptan—Feeling abnormal—Losartan—type 2 diabetes mellitus	9.1e-05	0.00086	CcSEcCtD
Tolvaptan—Dizziness—Valsartan—type 2 diabetes mellitus	9.03e-05	0.000853	CcSEcCtD
Tolvaptan—Anorexia—Ramipril—type 2 diabetes mellitus	9.03e-05	0.000853	CcSEcCtD
Tolvaptan—Dizziness—Orlistat—type 2 diabetes mellitus	8.92e-05	0.000843	CcSEcCtD
Tolvaptan—Asthenia—Metformin—type 2 diabetes mellitus	8.92e-05	0.000843	CcSEcCtD
Tolvaptan—Nausea—Gliclazide—type 2 diabetes mellitus	8.83e-05	0.000834	CcSEcCtD
Tolvaptan—Pruritus—Metformin—type 2 diabetes mellitus	8.8e-05	0.000831	CcSEcCtD
Tolvaptan—Body temperature increased—Losartan—type 2 diabetes mellitus	8.73e-05	0.000825	CcSEcCtD
Tolvaptan—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	8.65e-05	0.000817	CcSEcCtD
Tolvaptan—Headache—Valsartan—type 2 diabetes mellitus	8.55e-05	0.000808	CcSEcCtD
Tolvaptan—Diarrhoea—Metformin—type 2 diabetes mellitus	8.51e-05	0.000804	CcSEcCtD
Tolvaptan—Headache—Orlistat—type 2 diabetes mellitus	8.45e-05	0.000798	CcSEcCtD
Tolvaptan—Asthenia—Irbesartan—type 2 diabetes mellitus	8.42e-05	0.000795	CcSEcCtD
Tolvaptan—Pruritus—Irbesartan—type 2 diabetes mellitus	8.3e-05	0.000784	CcSEcCtD
Tolvaptan—Decreased appetite—Ramipril—type 2 diabetes mellitus	8.23e-05	0.000778	CcSEcCtD
Tolvaptan—Dizziness—Metformin—type 2 diabetes mellitus	8.22e-05	0.000777	CcSEcCtD
Tolvaptan—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	8.18e-05	0.000772	CcSEcCtD
Tolvaptan—Hypersensitivity—Losartan—type 2 diabetes mellitus	8.14e-05	0.000769	CcSEcCtD
Tolvaptan—Nausea—Valsartan—type 2 diabetes mellitus	8.11e-05	0.000766	CcSEcCtD
Tolvaptan—Constipation—Ramipril—type 2 diabetes mellitus	8.1e-05	0.000765	CcSEcCtD
Tolvaptan—Diarrhoea—Irbesartan—type 2 diabetes mellitus	8.03e-05	0.000758	CcSEcCtD
Tolvaptan—Nausea—Orlistat—type 2 diabetes mellitus	8.02e-05	0.000757	CcSEcCtD
Tolvaptan—Asthenia—Losartan—type 2 diabetes mellitus	7.92e-05	0.000748	CcSEcCtD
Tolvaptan—Pruritus—Losartan—type 2 diabetes mellitus	7.81e-05	0.000738	CcSEcCtD
Tolvaptan—Feeling abnormal—Ramipril—type 2 diabetes mellitus	7.8e-05	0.000737	CcSEcCtD
Tolvaptan—AVPR2—nephron tubule—type 2 diabetes mellitus	7.8e-05	0.225	CbGeAlD
Tolvaptan—Headache—Metformin—type 2 diabetes mellitus	7.79e-05	0.000736	CcSEcCtD
Tolvaptan—Dizziness—Irbesartan—type 2 diabetes mellitus	7.76e-05	0.000733	CcSEcCtD
Tolvaptan—Diarrhoea—Losartan—type 2 diabetes mellitus	7.56e-05	0.000714	CcSEcCtD
Tolvaptan—Body temperature increased—Ramipril—type 2 diabetes mellitus	7.49e-05	0.000707	CcSEcCtD
Tolvaptan—Nausea—Metformin—type 2 diabetes mellitus	7.39e-05	0.000698	CcSEcCtD
Tolvaptan—Headache—Irbesartan—type 2 diabetes mellitus	7.35e-05	0.000694	CcSEcCtD
Tolvaptan—Dizziness—Losartan—type 2 diabetes mellitus	7.3e-05	0.00069	CcSEcCtD
Tolvaptan—Hypersensitivity—Ramipril—type 2 diabetes mellitus	6.98e-05	0.000659	CcSEcCtD
Tolvaptan—Nausea—Irbesartan—type 2 diabetes mellitus	6.97e-05	0.000658	CcSEcCtD
Tolvaptan—Headache—Losartan—type 2 diabetes mellitus	6.92e-05	0.000654	CcSEcCtD
Tolvaptan—AVPR2—kidney—type 2 diabetes mellitus	6.86e-05	0.198	CbGeAlD
Tolvaptan—Asthenia—Ramipril—type 2 diabetes mellitus	6.79e-05	0.000642	CcSEcCtD
Tolvaptan—Pruritus—Ramipril—type 2 diabetes mellitus	6.7e-05	0.000633	CcSEcCtD
Tolvaptan—Nausea—Losartan—type 2 diabetes mellitus	6.56e-05	0.00062	CcSEcCtD
Tolvaptan—Diarrhoea—Ramipril—type 2 diabetes mellitus	6.48e-05	0.000612	CcSEcCtD
Tolvaptan—Dizziness—Ramipril—type 2 diabetes mellitus	6.26e-05	0.000591	CcSEcCtD
Tolvaptan—AVPR2—adipose tissue—type 2 diabetes mellitus	6.18e-05	0.178	CbGeAlD
Tolvaptan—Headache—Ramipril—type 2 diabetes mellitus	5.93e-05	0.00056	CcSEcCtD
Tolvaptan—Nausea—Ramipril—type 2 diabetes mellitus	5.63e-05	0.000531	CcSEcCtD
Tolvaptan—AVPR1A—liver—type 2 diabetes mellitus	5.23e-05	0.151	CbGeAlD
Tolvaptan—AVPR1A—Signaling Pathways—IRS2—type 2 diabetes mellitus	1.53e-05	0.000242	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—AGT—type 2 diabetes mellitus	1.53e-05	0.000242	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	1.52e-05	0.000241	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CDO1—type 2 diabetes mellitus	1.52e-05	0.000241	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GPD2—type 2 diabetes mellitus	1.52e-05	0.000241	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—IRS2—type 2 diabetes mellitus	1.52e-05	0.00024	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—AGT—type 2 diabetes mellitus	1.52e-05	0.00024	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—type 2 diabetes mellitus	1.51e-05	0.000238	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.5e-05	0.000238	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—LEP—type 2 diabetes mellitus	1.5e-05	0.000237	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—APOE—type 2 diabetes mellitus	1.5e-05	0.000237	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CALM1—type 2 diabetes mellitus	1.49e-05	0.000236	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—LEP—type 2 diabetes mellitus	1.49e-05	0.000235	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—APOE—type 2 diabetes mellitus	1.49e-05	0.000235	CbGpPWpGaD
Tolvaptan—CYP3A4—Biological oxidations—GSTM1—type 2 diabetes mellitus	1.48e-05	0.000235	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	1.48e-05	0.000234	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.48e-05	0.000234	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—APOA1—type 2 diabetes mellitus	1.47e-05	0.000233	CbGpPWpGaD
Tolvaptan—ABCB1—HIF-1-alpha transcription factor network—AKT1—type 2 diabetes mellitus	1.47e-05	0.000232	CbGpPWpGaD
Tolvaptan—CYP3A4—Metapathway biotransformation—GSTM1—type 2 diabetes mellitus	1.46e-05	0.000231	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—AK1—type 2 diabetes mellitus	1.45e-05	0.00023	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	1.41e-05	0.000224	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	1.41e-05	0.000224	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.41e-05	0.000223	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	1.4e-05	0.000222	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	1.38e-05	0.000218	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	1.37e-05	0.000217	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	1.36e-05	0.000216	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—MAT1A—type 2 diabetes mellitus	1.34e-05	0.000212	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—SLC5A4—type 2 diabetes mellitus	1.34e-05	0.000212	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.34e-05	0.000211	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—IRS1—type 2 diabetes mellitus	1.33e-05	0.00021	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—type 2 diabetes mellitus	1.31e-05	0.000208	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ND1—type 2 diabetes mellitus	1.29e-05	0.000205	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.29e-05	0.000205	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—HBA2—type 2 diabetes mellitus	1.29e-05	0.000205	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—G6PC—type 2 diabetes mellitus	1.29e-05	0.000205	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ENPP1—type 2 diabetes mellitus	1.29e-05	0.000205	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—INS—type 2 diabetes mellitus	1.28e-05	0.000202	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—INS—type 2 diabetes mellitus	1.27e-05	0.000201	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.26e-05	0.000199	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GCGR—type 2 diabetes mellitus	1.25e-05	0.000198	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CCL2—type 2 diabetes mellitus	1.25e-05	0.000198	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—type 2 diabetes mellitus	1.25e-05	0.000197	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.24e-05	0.000196	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.24e-05	0.000196	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.23e-05	0.000195	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—IGF1—type 2 diabetes mellitus	1.23e-05	0.000194	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—AKT2—type 2 diabetes mellitus	1.23e-05	0.000194	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—EGFR—type 2 diabetes mellitus	1.22e-05	0.000193	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	1.2e-05	0.00019	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—OXCT1—type 2 diabetes mellitus	1.18e-05	0.000187	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CYTB—type 2 diabetes mellitus	1.18e-05	0.000187	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.18e-05	0.000186	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	1.17e-05	0.000185	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—type 2 diabetes mellitus	1.16e-05	0.000183	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—SRD5A1—type 2 diabetes mellitus	1.15e-05	0.000182	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	1.15e-05	0.000181	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—BHMT—type 2 diabetes mellitus	1.13e-05	0.000179	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.12e-05	0.000178	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.12e-05	0.000178	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	1.11e-05	0.000176	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—NOS3—type 2 diabetes mellitus	1.11e-05	0.000176	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—HSD17B3—type 2 diabetes mellitus	1.1e-05	0.000174	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ACACA—type 2 diabetes mellitus	1.1e-05	0.000174	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—STAR—type 2 diabetes mellitus	1.1e-05	0.000174	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	1.1e-05	0.000174	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—type 2 diabetes mellitus	1.08e-05	0.000171	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—RELA—type 2 diabetes mellitus	1.06e-05	0.000167	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ABCC8—type 2 diabetes mellitus	1.05e-05	0.000167	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CBS—type 2 diabetes mellitus	1.05e-05	0.000167	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—RELA—type 2 diabetes mellitus	1.05e-05	0.000166	CbGpPWpGaD
Tolvaptan—ABCB1—islet of Langerhans—type 2 diabetes mellitus	1.04e-05	0.0302	CbGeAlD
Tolvaptan—CYP3A4—kidney—type 2 diabetes mellitus	1.04e-05	0.0301	CbGeAlD
Tolvaptan—ABCB1—Metabolism—COX2—type 2 diabetes mellitus	1.02e-05	0.000161	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—SLC5A2—type 2 diabetes mellitus	1.02e-05	0.000161	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—type 2 diabetes mellitus	1.01e-05	0.00016	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—NCOA6—type 2 diabetes mellitus	9.98e-06	0.000158	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—AANAT—type 2 diabetes mellitus	9.89e-06	0.000156	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PTGDS—type 2 diabetes mellitus	9.89e-06	0.000156	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—type 2 diabetes mellitus	9.83e-06	0.000156	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—HSD11B1—type 2 diabetes mellitus	9.81e-06	0.000155	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—UCP3—type 2 diabetes mellitus	9.81e-06	0.000155	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—UCP2—type 2 diabetes mellitus	9.81e-06	0.000155	CbGpPWpGaD
Tolvaptan—AVPR1A—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	9.62e-06	0.000152	CbGpPWpGaD
Tolvaptan—AVPR2—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	9.55e-06	0.000151	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—CASP3—type 2 diabetes mellitus	9.53e-06	0.000151	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	9.48e-06	0.00015	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—IL6—type 2 diabetes mellitus	9.47e-06	0.00015	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—CASP3—type 2 diabetes mellitus	9.46e-06	0.00015	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	9.44e-06	0.000149	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—IL6—type 2 diabetes mellitus	9.4e-06	0.000149	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GPD2—type 2 diabetes mellitus	9.38e-06	0.000148	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CDO1—type 2 diabetes mellitus	9.38e-06	0.000148	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	9.35e-06	0.000148	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PCK1—type 2 diabetes mellitus	9.22e-06	0.000146	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	9.04e-06	0.000143	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—type 2 diabetes mellitus	9.03e-06	0.000143	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—MMP9—type 2 diabetes mellitus	9.01e-06	0.000142	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—AK1—type 2 diabetes mellitus	8.95e-06	0.000141	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—MMP9—type 2 diabetes mellitus	8.94e-06	0.000141	CbGpPWpGaD
Tolvaptan—ABCB1—retina—type 2 diabetes mellitus	8.93e-06	0.0258	CbGeAlD
Tolvaptan—AVPR1A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	8.91e-06	0.000141	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—type 2 diabetes mellitus	8.85e-06	0.00014	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	8.85e-06	0.00014	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	8.73e-06	0.000138	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling by GPCR—AKT1—type 2 diabetes mellitus	8.67e-06	0.000137	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—HK1—type 2 diabetes mellitus	8.63e-06	0.000137	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	8.45e-06	0.000134	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—type 2 diabetes mellitus	8.43e-06	0.000133	CbGpPWpGaD
Tolvaptan—ABCB1—nephron tubule—type 2 diabetes mellitus	8.41e-06	0.0243	CbGeAlD
Tolvaptan—ABCB1—Metabolism—KCNJ11—type 2 diabetes mellitus	8.34e-06	0.000132	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GCKR—type 2 diabetes mellitus	8.34e-06	0.000132	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—LPA—type 2 diabetes mellitus	8.34e-06	0.000132	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—HSD3B2—type 2 diabetes mellitus	8.34e-06	0.000132	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—SRC—type 2 diabetes mellitus	8.3e-06	0.000131	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	8.26e-06	0.000131	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	8.26e-06	0.000131	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—SRC—type 2 diabetes mellitus	8.24e-06	0.00013	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	8.09e-06	0.000128	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	8.03e-06	0.000127	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ALDOB—type 2 diabetes mellitus	7.99e-06	0.000126	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	7.97e-06	0.000126	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	7.97e-06	0.000126	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	7.97e-06	0.000126	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	7.97e-06	0.000126	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	7.97e-06	0.000126	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	7.72e-06	0.000122	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	7.62e-06	0.000121	CbGpPWpGaD
Tolvaptan—ABCB1—cardiovascular system—type 2 diabetes mellitus	7.55e-06	0.0218	CbGeAlD
Tolvaptan—ABCB1—Metabolism—GLP1R—type 2 diabetes mellitus	7.43e-06	0.000118	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	7.42e-06	0.000117	CbGpPWpGaD
Tolvaptan—ABCB1—kidney—type 2 diabetes mellitus	7.39e-06	0.0213	CbGeAlD
Tolvaptan—AVPR2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	7.37e-06	0.000117	CbGpPWpGaD
Tolvaptan—ABCB1—pancreas—type 2 diabetes mellitus	7.34e-06	0.0212	CbGeAlD
Tolvaptan—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	7.29e-06	0.000115	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	7.29e-06	0.000115	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—EGFR—type 2 diabetes mellitus	7.28e-06	0.000115	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—EGFR—type 2 diabetes mellitus	7.22e-06	0.000114	CbGpPWpGaD
Tolvaptan—ABCB1—cortex of kidney—type 2 diabetes mellitus	7.19e-06	0.0208	CbGeAlD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	7.15e-06	0.000113	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	7.11e-06	0.000112	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—SLC2A2—type 2 diabetes mellitus	6.94e-06	0.00011	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—MTR—type 2 diabetes mellitus	6.8e-06	0.000108	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CPT1A—type 2 diabetes mellitus	6.8e-06	0.000108	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	6.78e-06	0.000107	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	6.78e-06	0.000107	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	6.78e-06	0.000107	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—NAMPT—type 2 diabetes mellitus	6.67e-06	0.000105	CbGpPWpGaD
Tolvaptan—ABCB1—adipose tissue—type 2 diabetes mellitus	6.66e-06	0.0192	CbGeAlD
Tolvaptan—ABCB1—Metabolism—HBA1—type 2 diabetes mellitus	6.62e-06	0.000105	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GCK—type 2 diabetes mellitus	6.62e-06	0.000105	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—LIPC—type 2 diabetes mellitus	6.62e-06	0.000105	CbGpPWpGaD
Tolvaptan—CYP3A4—liver—type 2 diabetes mellitus	6.6e-06	0.0191	CbGeAlD
Tolvaptan—ABCB1—Metabolism—CYP11A1—type 2 diabetes mellitus	6.58e-06	0.000104	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	6.5e-06	0.000103	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	6.5e-06	0.000103	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—SLC9A1—type 2 diabetes mellitus	6.47e-06	0.000102	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CETP—type 2 diabetes mellitus	6.39e-06	0.000101	CbGpPWpGaD
Tolvaptan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	6.28e-06	9.92e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	6.26e-06	9.89e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	6.26e-06	9.89e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	6.15e-06	9.72e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	6.04e-06	9.56e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	6.04e-06	9.56e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	6.04e-06	9.56e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—SNAP25—type 2 diabetes mellitus	5.94e-06	9.4e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—SREBF1—type 2 diabetes mellitus	5.94e-06	9.4e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PSMD6—type 2 diabetes mellitus	5.94e-06	9.4e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CTGF—type 2 diabetes mellitus	5.83e-06	9.22e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—HMGCR—type 2 diabetes mellitus	5.78e-06	9.14e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	5.68e-06	8.98e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	5.67e-06	8.96e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ADRA2A—type 2 diabetes mellitus	5.66e-06	8.95e-05	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—IL6—type 2 diabetes mellitus	5.59e-06	8.84e-05	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—IL6—type 2 diabetes mellitus	5.55e-06	8.78e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CYP2E1—type 2 diabetes mellitus	5.43e-06	8.59e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—SLC2A1—type 2 diabetes mellitus	5.37e-06	8.5e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CYP1A2—type 2 diabetes mellitus	5.37e-06	8.5e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	5.32e-06	8.41e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CYP3A4—type 2 diabetes mellitus	5.24e-06	8.29e-05	CbGpPWpGaD
Tolvaptan—AVPR1A—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.16e-06	8.16e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GCG—type 2 diabetes mellitus	5.15e-06	8.15e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—SLC2A4—type 2 diabetes mellitus	5.15e-06	8.15e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	5.14e-06	8.13e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	5.14e-06	8.13e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	5.14e-06	8.13e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	5.14e-06	8.13e-05	CbGpPWpGaD
Tolvaptan—AVPR2—Signaling Pathways—AKT1—type 2 diabetes mellitus	5.12e-06	8.1e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	4.93e-06	7.79e-05	CbGpPWpGaD
Tolvaptan—ABCB1—liver—type 2 diabetes mellitus	4.67e-06	0.0135	CbGeAlD
Tolvaptan—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	4.58e-06	7.24e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.44e-06	7.02e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	4.44e-06	7.02e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	4.42e-06	6.99e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	4.36e-06	6.9e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	4.28e-06	6.76e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	4.23e-06	6.7e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	4.19e-06	6.62e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	4.19e-06	6.62e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	4.12e-06	6.51e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	4.11e-06	6.5e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	4.08e-06	6.45e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	4.08e-06	6.45e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	4.08e-06	6.45e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	4.06e-06	6.41e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	4.04e-06	6.39e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	3.98e-06	6.3e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	3.96e-06	6.26e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	3.94e-06	6.24e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	3.94e-06	6.23e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	3.84e-06	6.07e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	3.79e-06	6e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	3.66e-06	5.79e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	3.66e-06	5.79e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	3.66e-06	5.79e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	3.64e-06	5.76e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	3.59e-06	5.68e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	3.57e-06	5.65e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	3.56e-06	5.63e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	3.48e-06	5.51e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	3.46e-06	5.47e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	3.4e-06	5.38e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	3.39e-06	5.36e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	3.35e-06	5.3e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	3.35e-06	5.3e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	3.31e-06	5.24e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	3.31e-06	5.24e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	3.17e-06	5.02e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	3.17e-06	5.02e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	2.95e-06	4.67e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—INS—type 2 diabetes mellitus	2.89e-06	4.58e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	2.74e-06	4.33e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.74e-06	4.33e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	2.72e-06	4.31e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	2.69e-06	4.25e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	2.65e-06	4.2e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	2.61e-06	4.13e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	2.54e-06	4.01e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	2.54e-06	4.01e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	2.54e-06	4.01e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	2.49e-06	3.94e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	2.44e-06	3.86e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	2.43e-06	3.84e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	2.37e-06	3.74e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	2.34e-06	3.7e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	2.32e-06	3.67e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	2.24e-06	3.55e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	2.2e-06	3.48e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	2.13e-06	3.37e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	2.1e-06	3.31e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	2.09e-06	3.3e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	2.06e-06	3.26e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.82e-06	2.88e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.78e-06	2.82e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.64e-06	2.59e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.56e-06	2.47e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.56e-06	2.47e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.43e-06	2.26e-05	CbGpPWpGaD
Tolvaptan—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	1.17e-06	1.85e-05	CbGpPWpGaD
Tolvaptan—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	7.19e-07	1.14e-05	CbGpPWpGaD
